1887
Volume 2025, Issue 3
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Celiac disease (CD) is a chronic immune-mediated disorder of the digestive system triggered by gluten ingestion among genetically predisposed individuals. It is a chronic disease that causes malnutrition, but it is a non-fatal condition. A significant proportion of cases remain undiagnosed due to asymptomatic or nonspecific presentations, contributing to delayed diagnosis and long-term complications. CD is not a contraindication for blood donation. This study aims to determine the seroprevalence of CD antibodies and the prevalence of biopsy-proven CD among blood donors.

A cross-sectional study was conducted on 1,497 blood donors (≥18 years) at Hamad Medical Corporation, Doha, Qatar, between 2018 and 2022. Serum anti-tissue transglutaminase IgA (anti-tTG IgA) and anti-endomysial IgA (anti-EM IgA) antibodies were measured in enrolled blood donors. Individuals with positive results for either antibody underwent esophagogastroduodenoscopy (EGD) with duodenal biopsies to confirm the diagnosis.

Serological testing revealed a seroprevalence of 0.8% (95% CI, 0.4%–1.4%) for anti-tTG IgA, with 83.3% of these individuals also being positive for anti-EM IgA. All seropositive individuals were male. Of 12 seropositive individuals, 4 (33%) consented to EGD and duodenal biopsy. Histological findings confirmed CD in two cases (50% of seropositive individuals who consented to biopsy). Both confirmed cases exhibited Marsh grade 2 changes.

The seroprevalence of CD antibodies among healthy blood donors was 0.8%, and biopsy-proven CD was 50% among seropositive individuals who consented to EGD. These findings highlight the presence of undiagnosed CD in this population, predominantly in males, and underscore the need for further community-based studies to assess the true prevalence and clinical implications of CD.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2025.80
2025-09-10
2026-04-15

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/qmj/2025/3/qmj.2025.80.html?itemId=/content/journals/10.5339/qmj.2025.80&mimeType=html&fmt=ahah

References

  1. Catassi C, Verdu EF, Bai JC, Lionetti E. Coeliac disease. Lancet. 2022Jun25; 399:(10344):2413–26. 10.1016/S0140-6736(22)007 94-2
    [Google Scholar]
  2. Makharia GK, Singh P, Catassi C, Sanders DS, Leffler D, Ali RAR, et al.. The global burden of coeliac disease: opportunities and challenges. Nat Rev Gastroenterol Hepatol. 2022May; 19:(5):313–27. 10.1038/s41575-021-00552-z
    [Google Scholar]
  3. Barada K, Bitar A, Mokadem MAR, Hashash JG, Green P. Celiac disease in Middle Eastern and North African countries: a new burden? World J Gastroenterol. 2010Mar;28; 16:(12):1449–57. 10.3748/wjg.v16.i12.1449
    [Google Scholar]
  4. Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders DS, Cellier C, et al.. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019Jun; 7:(5):583–613. 10.1177/205 0640619844125
    [Google Scholar]
  5. Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al.. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018Jun;1; 16:(6):823–36.e2. 10.1016/j.cgh.2017.06.037
    [Google Scholar]
  6. Ensari A, Marsh MN. Diagnosing celiac disease: a critical overview. Turk J Gastroenterol. 2019May; 30:(5):389–97. 10.5152/tjg.2018.18635
    [Google Scholar]
  7. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992Jan; 102:(1):330–54.
    [Google Scholar]
  8. Rostami K, Mulder CJ, Werre JM, van Beukelen FR, Kerchhaert J, Crusius JB, et al.. High prevalence of celiac disease in apparently healthy blood donors suggests a high prevalence of undiagnosed celiac disease in the Dutch population. Scand J Gastroenterol. 1999Mar; 34:(3):276–9. 10.1080/00365529950173681
    [Google Scholar]
  9. Shahbazkhani B, Malekzadeh R, Sotoudeh M, Moghadam KF, Farhadi M, Ansari R, et al.. High prevalence of coeliac disease in apparently healthy Iranian blood donors. Eur J Gastroenterol Hepatol. 2003May; 15:(5):475–8. 10.1097/01.meg.0000059118.41030.96
    [Google Scholar]
  10. Ludvigsson JF, Lebwohl B, Green PHR, Murray JA, Hjalgrim H, Edgren G. Is blood transfusion linked to celiac disease? A nationwide cohort study. Am J Epidemiol. 2018Jan;1; 187:(1):120–4. 10.1093/aje/kwx210
    [Google Scholar]
  11. Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, McMillan S, et al.. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med. 2010Dec; 42:(8):587–95. 10.3109/07853890.2010.505931
    [Google Scholar]
  12. Oliveira RP, Sdepanian VL, Barreto JA, Cortez AJP, Carvalho FO, Bordin JO, et al.. High prevalence of celiac disease in Brazilian blood donor volunteers based on screening by IgA antitissue transglutaminase antibody. Eur J Gastroenterol Hepatol. 2007Jan; 19:(1):43–9. 10.1097/01.meg.0000250586.61232.a3
    [Google Scholar]
  13. Remes-Troche JM, Ramírez-Iglesias MT, Rubio-Tapia A, Alonso-Ramos A, Velazquez A, Uscanga LF. Celiac disease could be a frequent disease in Mexico: prevalence of tissue transglutaminase antibody in healthy blood donors. J Clin Gastroenterol. 2006Sep; 40:(8):697–700. 10.1097/00004836-200609000-00007
    [Google Scholar]
  14. Tatar G, Elsurer R, Simsek H, Balaban YH, Hascelik G, Ozcebe OI, et al.. Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population. Dig Dis Sci. 2004Sep; 49:(9):1479–84. 10.1023/b:ddas.0000042250. 59327.91
    [Google Scholar]
  15. Kochhar R, Sachdev S, Kochhar R, Aggarwal A, Sharma V, Prasad KK, et al.. Prevalence of coeliac disease in healthy blood donors: a study from north India. Dig Liver Dis. 2012Jun;1; 44:(6):530–2. 10.1016/j.dld.2012.01.004
    [Google Scholar]
  16. Not T, Horvath K, Hill ID, Partanen J, Hammed A, Magazzu G, et al.. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol. 1998May; 33:(5):494–8. 10.1080/003655 29850172052
    [Google Scholar]
  17. Jansson-Knodell CL, Hujoel IA, West CP, Taneja V, Prokop LJ, Rubio-Tapia A, et al.. Sex difference in celiac disease in undiagnosed populations: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019Sep; 17:(10):1954–68.e13. 10.1016/j.cgh.2018.11.013
    [Google Scholar]
  18. Wikipedia . Demographics of Qatar;2024. https://en.wikipedia.org/w/index.php?title=Demographics_of_Qatar&oldid=1252923617 [Accessed 24 October 2024].
    [Google Scholar]
  19. Bani M, Giussani B. Gender differences in giving blood: a review of the literature. Blood Transfus. 2010Oct; 8:(4):278–87. 10.2450/2010.0156-09
    [Google Scholar]
  20. Rostami K, Mulder CJ, Werre JM, van Beukelen FR, Kerckhaert J, Crusius JB, et al.. High prevalence of celiac disease in apparently healthy blood donors suggests a high prevalence of undiagnosed celiac disease in the Dutch population. Scand J Gastroenterol. 1999Jan;1; 34:(3):276–9. 10.1080/00365529950173681
    [Google Scholar]
  21. Shamir R, Lerner A, Shinar E, Lahat N, Sobel E, Bar-or R, et al.. The use of a single serological marker underestimates the prevalence of celiac disease in Israel: a study of blood donors. Am J Gastroenterol. 2002Oct; 97:(10):2589–94. 10.1111/j.1572-0241.2002.06028.x
    [Google Scholar]
/content/journals/10.5339/qmj.2025.80
Loading
/content/journals/10.5339/qmj.2025.80
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): anti-endomysial antibodyanti-tissue transglutaminase antibodyblood donors and Celiac disease
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error